HomeProductsBuilding BlocksCarbocyclic ScaffoldsBenzene CompoundsRonacaleret
Chemical structure of CAS 753449-67-1

Ronacaleret

CAS No.753449-67-1
MDL No.N/A
MFC25H31F2NO4
MW447.50
InChI KeyFQJISUPNMFRIFZ-HXUWFJFHSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.753449-67-1
Product NameRonacaleret

Biological Targets

CASR

Associated Conditions

bone fracture·osteoporosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • Vol. 27, Issue 2 • 2012
PMID: 22052452DOI: 10.1002/jbmr.554

[Update and perspectives of anabolic therapies for osteoporosis].

Clinical calcium • Vol. 22, Issue 3 • 2012
PMID: 22370299

Bone: Ronacaleret in osteoporosis.

Nature reviews. Endocrinology • Vol. 8, Issue 2 • 2011
PMID: 22124441DOI: 10.1038/nrendo.2011.212

Hypercalcemia reduces plasma renin via parathyroid hormone, renal interstitial calcium, and the calcium-sensing receptor.

Hypertension (Dallas, Tex. : 1979) • Vol. 58, Issue 4 • 2011
PMID: 21825222PMC: PMC3174336DOI: 10.1161/HYPERTENSIONAHA.111.172890

Documentation